Methadone Diversion: Why it happens, what the illicit market looks like and the implications

Similar documents
Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

ILLICIT USE OF FENTANYL PATCHES IN RURAL AUSTRALIA

Buprenorphine treatment

You will be prescribed a preparation in the strength of 1mg/1ml. Methadone, like heroin can also cause a physical dependence.

Drug Misuse and Dependence Guidelines on Clinical Management

IMPLICATIONS OF LONG-TERM HEROIN USE AMONG MEXICAN AMERICAN USERS: THE MATURING OUT PARADOX

The science of the mind: investigating mental health Treating addiction

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Treatment of drug dependence What you need to know

Substance use and misuse

Data Driven Strategies

Welcome to your Addiction Recovery Community Hub. Patient information leaflet ARCH North

Medication-Assisted Treatment. What Is It and Why Do We Use It?

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

WHAT IS HARM REDUCTION?

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

Insight Addictionary

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP

Criminal Justice Project: Drug Interventions Programme

Methadone 6. meth : physeptone : juice WHAT & WHY? No. 6 in a series of guides to help people understand what drugs are and why people take them

Models of good practice in drug treatment in Europe. Project group

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Brief History of Methadone Maintenance Treatment

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

How serious is the opiate problem in Fairfield County?

Guidelines For Services Providing Injecting Equipment

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Incorporating Harm Reduction Strategies in Behavioral Health Grantmaking October 25, :00 p.m. Eastern

1.4 The CADAS teams do not provide a service for residents of Bournemouth or Poole.

Drug Trend Bulletin Issue 13 September 2016.

Illicit drug use in prisons

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies

What is harm reduction?

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Proper Use of Prescription Stimulant Medication

Overview of Opiate Addiction

Housing Ready vs. Housing First. Mission: 2/21/17

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Analysis of the 2017 Imagine RIT Attendees Perceptions of Opioids and the Opioid Epidemic

Substance Use Trends in the Military, Veteran and Family Population

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2012

A prisoners guide to buprenorphine

Substance Misuse and Domestic Abuse: Dual Issues, an Integrated Response A study in County Durham. Frazer Hill Gail Murphy

Take Home Naloxone Report on supply and use to reverse an overdose

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Hospitals Role in Addressing the Opioid Crisis

The drugs situation in Ireland: an overview of trends from 2005 to 2015.

Addiction and Substance misuse pathways

Opioid epidemic and PEHP

REFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre.

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.

Taking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on Long-term Opioid Therapy for Chronic Pain

Ahsan U. Rashid, M.D., F.A.C.P.

Prescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

Quality assurance and quality improvement of chronic nonmalignant

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Take Home Naloxone elearning Module Script

Addressing Alaska s Opioid Epidemic From Understanding to Action

The Parents Back to School Kit Part 2 Kids and the misuse of Medications

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Substance Abuse Suboxone Treatment

The Opioid Epidemic: Overdose Data in NYC

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

University of Pittsburgh

Informal meeting of the Justice and Home Affairs Ministers Sopot July 2011

NPS use in Lothian. Linda J Smith BBV Prevention Worker (RN/RMHN) Harm Reduction Team

Anyone Can Become Addicted. Anyone.

National Guidelines. Interim methadone prescribing

The Phoenix ESTLR/STAR Pre-Screening Form

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

The Nature of Methadone Diversion in England: A Merseyside case study

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

Prescription Painkiller Abuse in Wisconsin Sharing a Dose of Reality. Brad Schimel Wisconsin Attorney General

The Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users

1. Please describe the personal attributes and skills that you consider desirable for a member of CRHT.

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Blount County Community Justice Initiative

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Hard Edges Scotland: Lived Experience Reference Group

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

HA Corporate Scholarship Program:

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative

Drug Use, Harm Reduction, and HIP

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

Harm Reduction Approaches:

Building Community Coalitions to Address the Opioid Crisis

Service Level Agreement. for the Enhanced. Pharmaceutical Service. Administration of Medication. Between Turning Point &

We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit

Should buprenorphine be covered for maintenance treatment in opioid dependent persons?

Managing the Drug-Free Workplace Quiz

Transcription:

Methadone Diversion: Why it happens, what the illicit market looks like and the implications Paul Duffy & Helen Baldwin Centre for Public Health Liverpool John Moores University

Methadone provision and diversion International research has supported the role of methadone maintenance in: Reducing illicit opioid use Maintaining engagement with treatment Reducing injecting and sharing of drug taking equipment Reducing mortality (overdose related and not) Improving employment prospects

Methadone provision and diversion In the UK and in many other countries continues to be the main choice for opiate substitution BUT Diversion of methadone onto to black market is a concern Unless prescribed under the correct circumstances can simply be an add-on rather than a substitute Involvement in treatment can create market for illicit methadone as clients look to supplement Diversion can be associated with overdose

Geography

Research rationale Substantial numbers of drug users arrested were reporting illicit methadone use UK focus on engaging with clients in the criminal justice system has identified the high numbers of clients who are in treatment who continue to offend Little recent UK research into methadone diversion, none in this geography Emergence of alternative substitute medication Renewed focus on the recovery agenda raises additional questions about the widespread use of methadone

Research aims To examine the extent and nature of the market for illicit methadone in Merseyside To examine the reasons why drug users make use of and contribute to this market To examine doctors, drug workers and pharmacists view of diversion of methadone and actions to tackle this To examine the methadone prescribing and dispensing practices among treatment agencies and pharmacists across Merseyside and consider how this might influence diversion

Methodology 1. Client questionnaires Approx. 900 across Merseyside (673 completed currently) in treatment and non treatment settings (homeless shelters, service user forums) 2. Interviews with: Drugs workers Doctors Methadone dispensing pharmacists 3. Proforma asking for details of the level and nature of prescriptions and adherence to guidelines from each agency

Sample characteristics 71% male, Mean age 37.96 89% recruited within a treatment service 97% prescribed methadone currently or in past year 60 50 50 % 40 30 20 10 0 26 10 1 1 64% of clients were on daily pick up 0-40mg 41-80mg 81-120mg 121-160mg More than 160mg Daily Dose

Why clients use methadone % 90 80 70 60 50 40 30 20 10 0 77 Reduce withdrawal 19 Reduce unpleasant mental state 3 Provide a 'hit' 32 Other Reason for using their prescribed methadone

Supervised consumption 49% were on supervised consumption 62% of these said they would prefer not to be because: Taking their methadone in the chemists was embarrassing/degrading They found going to the chemist every day inconvenient and in some cases difficult due to health problems They wanted to split their dose, particularly saving some for later on in the evening

Extent of the market (1) 70 60 60 50 % 40 30 23 20 13 10 5 0 Obtained in past year Obtained in past 4 weeks Provided in past year Provided in past 4 weeks 76% of clients said they knew at least one person who regularly provided methadone (13% said they knew 15 or more people) 73% of clients said they knew at least one person who regularly obtained methadone (16% said they knew 15 or more people)

Extent of the market (2) The substantial differences in the proportions of clients reporting obtaining and providing methadone may suggest: Clients were not being 100% honest We were not speaking to the clients who were diverting their methadone 80 70 60 59 67 50 % 40 30 20 10 0 23 25 4 18 11 33 Treatment Agency Other Obtained past 4 weeks Obtained past year Provided past 4 weeks Provided past year

Nature of the market Clients who had obtained or provided methadone generally had done so from/to friends or acquaintances Obtaining methadone off a dealer was very rare Similar proportions of clients had been given methadone for free and had bought it (44% and 43% ) Giving methadone away for free was the most common way of providing it, not trading or selling it Previous work on methadone diversion has suggested the primary motivation is financial (to gain money for other drugs) this does NOT appear to the primary driver in this instance. 82% who had provided methadone had done so to help someone 21% to obtain money for other drugs

Why use the market for illicit methadone? Missed pick-up 50% Missed treatment appointment 31% To top up prescription 28% When clients did miss a pick-up: 42% used other drugs 32% used illicit methadone 17% went without anything

Continued drug use % 80 70 60 50 40 68 58 50 40 34 30 20 15 10 3 3 2 1 1 0 Drugs used in the past 4 wks Common drug use combinations: 52% heroin and methadone together 39% methadone and alcohol 20% methadone and benzodiazepines 14% alcohol and benzodiazepines

Conclusions Despite high levels of supervised consumption/daily pick up, Merseyside has a considerable market for illicit methadone the original source of which is not clear (non agency prescribing?) The market is only to some degree cash based and there is an altruistic element to it Supervised consumption was not popular. More consideration needs to be given to the suitability of locations for consumption and the use of split supervised and take home doses The implications of clients missing pick-ups are substantial as many turn to street drugs. Innovative ways of preventing this need to be considered Large proportions of clients continue to use street drugs whilst prescribed potentially in harmful ways, how much this reflects clients motivation or appropriateness of prescribing must be investigated Future work looking at methadone diversion must recruit as much from outside treatment agencies as possible